GlassScriptPhysician profile
Brandon Jacob Smith
NPI 1598387185
$1,954.14
in general payments reported to CMS, 2019-2025
9 companies · $672 in 2025
The $672 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $193 · 2024: $1,089 · 2025: $672.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,954.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,954.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $773.99 | 2023-2025 | Sprint Pns System |
| Nevro Corp. | $416.70 | 2023-2024 | Senza |
| Stratus Medical, LLC | $182.87 | 2025 | Nimbus |
| Medtronic, INC. | $166.31 | 2024-2025 | Vectris Surescan, Intellis Adaptivestim, Synchromedii |
| Saluda Medical Americas, INC. | $116.95 | 2024 | Evoke |
| Globus Medical, INC. | $111.12 | 2025 | Senza |
| Novo Nordisk INC | $100.04 | 2025 | Wegovy |
| Stryker Corporation | $60.35 | 2025 | Mild Device Kit, Omnicurve, Optablate |
| Boston Scientific Corporation | $25.81 | 2025 | Intracept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.